Amrutanjan Health Care Limited — PPTs, 09-05-2026: Investor Presentation

Amrutanjan Health Care delivered strong FY26 results with Net Sales up 11.23% to Rs 502.55 Cr and Profit After Tax rising 13.95% to Rs 57.92 Cr. Profit before exceptional items jumped 25.47%. Growth was driven by power brands Amrutanjan and Comfy, with Pain Management (+10%) and Women's Hygiene (+19%) segments leading the way.

The company is aggressively expanding market reach through initiatives like rural van activities and aiming to add 100K new chemists by September FY27. A key focus is evolving Comfy into an 'Overall Women's Wellness' brand.

Q4 saw new product launches, including Women’s and Men’s Razors, Ortho Pain Oil, and Nasal Spray, expanding its portfolio. The sales network grew significantly, with stockists up 9% and total outlet coverage up 12%. A new sanitary pad plant will commence production in May.

For FY26, Net Sales grew 11.23% to Rs 502.55 Cr, and Profit After Tax increased 13.95% to Rs 57.92 Cr.

Management is confident in future demand, planning to relaunch the Congestion brand Relief. They expect COGS inflation but are managing it with price adjustments. The new sanitary pad plant should boost Comfy's profitability. A one-time charge of Rs 7.6 Cr (legal case) and Rs 1.25 Cr (labor codes) impacted recent results.